Sign in

CIK 0001020214 · Accelerated filer

CERUS CORP

Sign in to watch
Ticker
CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
680262011
Phone
9252886000
Business address
1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
  1. 4 Open-market buy Director bought 2,500 shares at $1.88 ($4,689)
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. DEFA14A Proxy Proxy Materials
  5. DEF 14A Proxy Proxy Statement
  6. ARS Other Annual Report to Security Holders
  7. 8-K Event Other events
  8. 4 Open-market sale Chief Financial Officer sold 42,555 shares at an average $1.99 ($84,882)
  9. 4 Open-market sale SVP Reg. & Quality sold 20,619 shares at an average $2.02 ($41,553)
  10. 4 Open-market sale Chief Legal Officer sold 35,284 shares at an average $2.02 ($71,107)
  11. 4 Open-market sale Chief Operating Officer sold 53,041 shares at an average $2.02 ($106,892)
  12. 4 Open-market sale President and CEO sold 125,926 shares at an average $2.04 ($256,377)
  13. 4 Open-market sale Chief Scientific Officer sold 28,427 shares at an average $2.02 ($57,288)
  14. 4 Open-market sale Chief Medical Officer sold 35,115 shares at an average $2.02 ($70,766)
  15. 4 Open-market sale Chief Medical Officer sold 29,378 shares at $2.40 ($70,457)
  16. 144 Insider Sale of Securities
  17. 4 Grant or award SVP Reg. & Quality acquired 75,000 shares (grant or award)
  18. 4 Grant or award Chief Legal Officer acquired 160,000 shares (grant or award)
  19. 4 Grant or award Chief Operating Officer acquired 240,000 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 575,000 shares (grant or award)

Page 9 of 76 · 1,513 filings